JMP Securities Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
Regional Management (RM) Gets a Hold from JMP Securities
In a report released today, David Scharf from JMP Securities reiterated a Hold rating on Regional Management (RM – Research Report). The ...
JMP Securities holds Snap stock at $16 target, cites strong 4Q24
JMP Securities maintained a bullish stance on Snap Inc (NYSE: NYSE:SNAP), reiterating their Market Outperform rating with a $16.00 price target. The endorsement follows Snap's release of its ...
JMP Securities maintains Carvana stock with $320 target
JMP Securities reiterated a Market Outperform rating on Carvana (NYSE:CVNA) shares, maintaining a $320.00 price target. The firm's analysis hinges on a long-term 'blue sky' scenario where Carvana ...
The Lancet2d
Optimising quadruplet regimens to broaden eligibility in multiple myeloma
The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...
Scientific Research Publishing6d
Design of a Noninvasive Bladder Urinary Volume Monitoring System Based on Bio-Impedance ()
For the needs of bladder urinary volume noninvasive monitoring in clinical, we present a noninvasive bladder urinary volume monitoring system based on bio-impedance. The system uses a four-electrode ...